artenimol has been researched along with Alzheimer Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Dong, Z; Du, Y; Li, J; Luo, M; Pang, Y; Wang, Y; Wu, B; Xia, L | 1 |
| He, G; Idris, NFB; Liu, Y; Long, Z; Luo, M; Qiu, Y; Song, A; Wang, K; Zhao, Y | 1 |
2 other study(ies) available for artenimol and Alzheimer Disease
| Article | Year |
|---|---|
Dihydroartemisinin Induces O-GlcNAcylation and Improves Cognitive Function in a Mouse Model of Tauopathy.
Topics: Alzheimer Disease; Animals; Antimalarials; Artemisinins; Brain; Cognition; Disease Models, Animal; Humans; Learning; Long-Term Potentiation; Mice; Neuroprotective Agents; Phosphorylation; Tauopathies | 2021 |
Dihydroartemisinin Ameliorates Decreased Neuroplasticity-Associated Proteins and Excessive Neuronal Apoptosis in APP/PS1 Mice.
Topics: Alzheimer Disease; Animals; Antimalarials; Apoptosis; Artemisinins; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Hippocampus; Humans; Male; Memory; Mice; Mice, Transgenic; Neuronal Plasticity; Neuroprotective Agents | 2020 |